Lantheus Holdings, Inc. Interest Expense
Lantheus Holdings, Inc. (LNTH) reported Interest Expense of $4.86 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-02.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-02
- Lantheus Holdings, Inc. interest expense for the quarter ending 2024-03-31 was $4.86M, a 2.64% decline year-over-year.
- Lantheus Holdings, Inc. interest expense for the quarter ending 2023-12-31 was $5.04M, a 95.31% increase year-over-year.
- Lantheus Holdings, Inc. interest expense for the quarter ending 2023-09-30 was $5.05M, a 210.82% increase year-over-year.
- Lantheus Holdings, Inc. interest expense for the quarter ending 2023-06-30 was $4.93M, a 235.81% increase year-over-year.
- Lantheus Holdings, Inc. interest expense for fiscal 2023 was $20.02M, a 178.62% increase from fiscal 2022.
- Lantheus Holdings, Inc. interest expense for fiscal 2022 was $7.18M, a 7.31% decline from fiscal 2021.
- Lantheus Holdings, Inc. interest expense for fiscal 2021 was $7.75M, a 18.22% decline from fiscal 2020.
- Lantheus Holdings, Inc. interest expense for fiscal 2020 was $9.48M, a 30.39% decline from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month |
|---|---|---|---|---|---|
| 2024-03-31 | $4.86M 10-Q · filed 2024-05-02 | $9.90M derived: sum of 2 quarters · filed 2024-05-02 | $14.95M derived: sum of 3 quarters · filed 2024-05-02 | $19.89M derived: sum of 4 quarters · filed 2024-05-02 | |
| 2023-12-31 | $5.04M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $10.10M derived: sum of 2 quarters · filed 2024-02-22 | $15.03M derived: sum of 3 quarters · filed 2024-02-22 | $20.02M 10-K · filed 2024-02-22 | |
| 2023-09-30 | $5.05M 10-Q · filed 2023-11-02 | $9.99M derived: sum of 2 quarters · filed 2023-11-02 | $14.98M 10-Q · filed 2023-11-02 | $17.56M derived: sum of 4 quarters · filed 2024-05-02 | |
| 2023-06-30 | $4.93M 10-Q · filed 2023-08-03 | $9.92M 10-Q · filed 2023-08-03 | $12.51M derived: sum of 3 quarters · filed 2024-05-02 | $14.13M derived: sum of 4 quarters · filed 2024-05-02 | |
| 2023-03-31 | $4.99M 10-Q · filed 2024-05-02 | $7.57M derived: sum of 2 quarters · filed 2024-05-02 | $9.20M derived: sum of 3 quarters · filed 2024-05-02 | $10.67M derived: sum of 4 quarters · filed 2024-05-02 | |
| 2022-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $4.21M derived: sum of 2 quarters · filed 2024-02-22 | $5.68M derived: sum of 3 quarters · filed 2024-02-22 | $7.18M 10-K · filed 2024-02-22 | |
| 2022-09-30 | $1.63M 10-Q · filed 2023-11-02 | $3.10M derived: sum of 2 quarters · filed 2023-11-02 | $4.60M 10-Q · filed 2023-11-02 | $6.13M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-06-30 | $1.47M 10-Q · filed 2023-08-03 | $2.98M 10-Q · filed 2023-08-03 | $4.51M derived: sum of 3 quarters · filed 2024-02-22 | $6.08M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-03-31 | $1.51M 10-Q · filed 2023-05-04 | $3.04M derived: sum of 2 quarters · filed 2024-02-22 | $4.61M derived: sum of 3 quarters · filed 2024-02-22 | $6.54M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2021-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $3.10M derived: sum of 2 quarters · filed 2024-02-22 | $5.03M derived: sum of 3 quarters · filed 2024-02-22 | $7.75M 10-K · filed 2024-02-22 | |
| 2021-09-30 | $1.57M 10-Q · filed 2022-11-03 | $3.51M derived: sum of 2 quarters · filed 2022-11-03 | $6.22M 10-Q · filed 2022-11-03 | $9.04M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-06-30 | $1.94M 10-Q · filed 2022-08-04 | $4.66M 10-Q · filed 2022-08-04 | $7.47M derived: sum of 3 quarters · filed 2023-02-23 | $10.27M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-03-31 | $2.72M 10-Q · filed 2022-04-29 | $5.53M derived: sum of 2 quarters · filed 2023-02-23 | $8.34M derived: sum of 3 quarters · filed 2023-02-23 | $10.25M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2020-12-31 | $2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $5.62M derived: sum of 2 quarters · filed 2023-02-23 | $7.53M derived: sum of 3 quarters · filed 2023-02-23 | $9.48M 10-K · filed 2023-02-23 | |
| 2020-09-30 | $2.81M 10-Q · filed 2021-11-04 | $4.72M derived: sum of 2 quarters · filed 2021-11-04 | $6.67M 10-Q · filed 2021-11-04 | $8.79M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-30 | $1.91M 10-Q · filed 2021-07-28 | $3.86M 10-Q · filed 2021-07-28 | $5.99M derived: sum of 3 quarters · filed 2022-02-24 | $8.34M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-31 | $1.95M 10-Q · filed 2021-05-04 | $4.07M derived: sum of 2 quarters · filed 2022-02-24 | $6.43M derived: sum of 3 quarters · filed 2022-02-24 | $10.97M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2019-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $4.48M derived: sum of 2 quarters · filed 2022-02-24 | $9.03M derived: sum of 3 quarters · filed 2022-02-24 | $13.62M 10-K · filed 2022-02-24 | |
| 2019-09-30 | $2.36M 10-Q · filed 2020-11-05 | $6.90M derived: sum of 2 quarters · filed 2020-11-05 | $11.49M 10-Q · filed 2020-11-05 | $16.10M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-06-30 | $4.54M 10-Q · filed 2020-07-31 | $9.13M 10-Q · filed 2020-07-31 | $13.75M derived: sum of 3 quarters · filed 2021-02-25 | $18.19M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-03-31 | $4.59M 10-Q · filed 2020-04-30 | $9.20M derived: sum of 2 quarters · filed 2021-02-25 | $13.65M derived: sum of 3 quarters · filed 2021-02-25 | $17.95M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2018-12-31 | $4.61M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $9.06M derived: sum of 2 quarters · filed 2021-02-25 | $13.36M derived: sum of 3 quarters · filed 2021-02-25 | $17.41M 10-K · filed 2021-02-25 | |
| 2018-09-30 | $4.45M 10-Q · filed 2019-10-31 | $8.74M derived: sum of 2 quarters · filed 2019-10-31 | $12.79M 10-Q · filed 2019-10-31 | $17.06M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-06-30 | $4.30M 10-Q · filed 2019-07-25 | $8.35M 10-Q · filed 2019-07-25 | $12.61M derived: sum of 3 quarters · filed 2020-02-25 | $17.05M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-03-31 | $4.05M 10-Q · filed 2019-04-30 | $8.31M derived: sum of 2 quarters · filed 2020-02-25 | $12.76M derived: sum of 3 quarters · filed 2020-02-25 | $17.04M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2017-12-31 | $4.26M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $8.71M derived: sum of 2 quarters · filed 2020-02-25 | $12.99M derived: sum of 3 quarters · filed 2020-02-25 | $18.41M 10-K · filed 2020-02-25 | |
| 2017-09-30 | $4.44M 10-Q · filed 2018-10-30 | $8.73M derived: sum of 2 quarters · filed 2018-10-30 | $14.15M 10-Q · filed 2018-10-30 | $19.97M derived: sum of 4 quarters · filed 2019-02-20 | |
| 2017-06-30 | $4.29M 10-Q · filed 2018-08-01 | $9.71M 10-Q · filed 2018-08-01 | $15.52M derived: sum of 3 quarters · filed 2019-02-20 | $22.31M derived: sum of 4 quarters · filed 2019-02-20 | |
| 2017-03-31 | $5.42M 10-Q · filed 2018-05-02 | $11.24M derived: sum of 2 quarters · filed 2019-02-20 | $18.02M derived: sum of 3 quarters · filed 2019-02-20 | $25.01M derived: sum of 4 quarters · filed 2019-02-20 | |
| 2016-12-31 | $5.82M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $12.61M derived: sum of 2 quarters · filed 2019-02-20 | $19.59M derived: sum of 3 quarters · filed 2019-02-20 | $26.62M 10-K · filed 2019-02-20 | |
| 2016-09-30 | $6.79M 10-Q · filed 2017-11-02 | $13.77M derived: sum of 2 quarters · filed 2017-08-01 | $20.80M 10-Q · filed 2017-11-02 | $20.78M 10-Q · filed 2016-11-01 | $27.91M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $6.98M 10-Q · filed 2017-08-01 | $14.01M 10-Q · filed 2017-08-01 | $21.12M derived: sum of 3 quarters · filed 2018-02-26 | $28.22M derived: sum of 4 quarters · filed 2018-02-26 | |
| 2016-03-31 | $7.02M 10-Q · filed 2017-05-02 | $14.14M derived: sum of 2 quarters · filed 2018-02-26 | $21.24M derived: sum of 3 quarters · filed 2018-02-26 | $35.12M derived: sum of 4 quarters · filed 2018-02-26 | |
| 2015-12-31 | $7.12M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $14.22M derived: sum of 2 quarters · filed 2018-02-26 | $28.09M derived: sum of 3 quarters · filed 2018-02-26 | $38.72M 10-K · filed 2018-02-26 | |
| 2015-09-30 | $7.10M 10-Q · filed 2016-11-01 | $20.98M derived: sum of 2 quarters · filed 2016-11-01 | $31.60M 10-Q · filed 2016-11-01 | ||
| 2015-06-30 | $13.88M 10-Q · filed 2015-08-05 | $24.50M 10-Q · filed 2015-08-05 | |||
| 2014-12-31 | $42.29M 10-K · filed 2017-02-23 | ||||
| 2014-06-30 | $10.57M 10-Q · filed 2015-08-05 | $21.12M 10-Q · filed 2015-08-05 | |||
| 2013-12-31 | $42.91M 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |